go to the Content

Assistive Product PARI Basic

Product Type

Nozzle nebulizer

Indications

  • asthma
  • bronchitis
  • allergies
  • minor infections
  • preventive care of the respiratory tract

Description

The PARI Basic inhaler is equally suitable for the home and travel pharmacy and can be operated worldwide from the mains.

Features / Components

  • medication nebulizer for the lower respiratory tract
  • basic device with power supply
  • with PARI LC PLUS nebulizer
  • can be retrofitted with PARI LC SPRINT nebulizer
  • with mouthpiece and children's mask
  • with connection tube
  • company with mains and rechargeable battery
  • can be extended with PARI BASIC mobile set (PZN: 6494322) including rechargeable battery (approx. 8 inhalations) and bag for mains-independent use

Price (without guarantee)

The price is available on request from the manufacturer / distributor.

SHI-Number

SHI-Medical Technical Aids Register

14.24.01.0106

Product Information from the Manufacturer / Distributor

Further Product Details

REHADAT does not sell any products

Please contact the manufacturer or distributor.

Manufacturer

PARI Medical Holding GmbH
Moosstr. 3
82319 Starnberg
Germany
08151 279-0
info@pari.de
https://www.pari.com

Distributor

PARI Medical Holding GmbH
Moosstr. 3
82319 Starnberg
Germany
08151 279-0
info@pari.de
https://www.pari.com

Technical Data

Weight: 360 g
Dimensions (W x H x D): 8.9 x 4.5 x 11.3 cm
Voltage: 100-240 V AC, 50-60 Hz; 12 V DC
Operating noise: approx. 52 dB(A)
Nebulizer output: 360 mg/min (PARI LC PLUS)
440 mg/min (PARI LC SPRINT)
Pressure: 1 bar
Flow (inspiratory): 20 l/min
Compressor flow: 3.8 l/min
Nebulized medium: 0.9 percent NaCl (5ml)
Med. Mass diameter: 3.7 micrometers (PARI LC PLUS)
3.8 micrometers (PARI LC SPRINT)
Particle size: 66 percent < 5 micrometers (PARI LC PLUS)
65 percent < 5 micrometers (PARI LC SPRINT)
Operating mode: Intermittent operation (30 min ON / 30 min OFF)
Pharma central number: 6116525

ICF Items

Reference Number:

IW/040306.114


Last Update: 17 Jan 2025